http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2285300-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de9d4d365fd170c472aaeec4421e1237 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G09B23-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
| filingDate | 2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3f784ce8e04cbb6134f55015ada70e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a1567ce6bd725e1c393b49a64b3cac6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_325217265e0a4344537ef9b953f699ab |
| publicationDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2285300-C1 |
| titleOfInvention | Method for correcting affected erythropoiesis at experimental hypoxia |
| abstract | FIELD: medicine, pharmacology. n SUBSTANCE: the present innovation deals with correcting affected erythropoiesis in case of severe hypoxia. One should fulfill subcutaneous single injection of propranolol for laboratory mice on the 2 nd d after hypoxia modeling at the dosage of 5 mg/kg. The innovation enables to improve the dynamics for reconstructing cellularity and qualitative values of erythroid source of blood formation, increase the number of erythrocytes in peripheral blood at decreasing the production of their pathological forms due to preventing the lesion of commitment precursor cells of erythropoiesis in post-hypoxic period. n EFFECT: higher efficiency of correction. n 3 ex, 3 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2528976-C1 |
| priorityDate | 2005-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.